Abstract
Lipoidal vesicular systems, including liposomes, ethosomes, and transferosomes, represent a significant advancement in targeted drug delivery, offering enhanced bioavailability, controlled release, and specific targeting capabilities. This review discusses the types of lipoidal vesicular systems, their methods of characterization, method development, applications, advantages, challenges, and future perspectives. These systems have shown immense potential in diverse therapeutic areas, including cancer therapy, infectious diseases, gene therapy, and transdermal drug delivery. Despite the challenges in stability, scalability, and targeting, ongoing research and technological advancements promise to expand their applications and improve therapeutic outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
